Charming Medical Limited
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| – | -23.5% | +9.7% | +84.3% | |
| – | -11.0% | -8.2% | +142.8% | |
| – | +9.0% | -61.2% | +475.3% | |
| – | +9.0% | +31.3% | – | |
| – | -27.7% | -62.3% | -65.2% | |
| – | -57.6% | -4.8% | -4.4% | |
| – | -21.2% | -12.0% | -11.7% | |
| – | -18.0% | -15.8% | -12.5% | |
| – | -38.6% | -1.3% | – | |
| – | -100.0% | – | +394.3% | |
| – | – | – | +10,421.2% | |
| – | – | – | -19.0% | |
| – | +0.0% | +0.0% | +1.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.